IBIsrael Moshe Barbash

Israel Moshe Barbash

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Israel Moshe Barbash has a total of 195 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Incidence and Predictors of Complications After Transcatheter Aortic Valve Implantation According to VARC‐3 Criteria: A Systematic Review and Meta‐Analysis

    by Federico Giacobbe, Francesco Bruno, Marco Brero, Pierre Meynet, Andrea Solano, Sergio Capoccia, Riccardo Pilia, Fabrizio D’AScenzo, Federico Conrotto, Giuseppe Tarantini, et al.

    Background: Despite continuous advancements in devices and techniques, transcatheter aortic valve implantation remains associated with complications impacting outcomes. In 2021, the Valve Academic Research Consortium (VARC) introduced the VARC‐3 criteria to better classify procedural complications. Methods: We conducted a systematic review and meta‐analysis of studies reporting transcatheter aortic valve implantation‐related complications using VARC‐3 definitions between 2021 and 2025. The primary end point was all‐cause mortality at latest follow‐up. Secondary end points included major VARC‐3 complications and predictors of adverse events. Results: A total of 57 studies with 73 588 patients were included. The cohort had a mean age of 81.7 years, 51.7% were women, and most had preserved ejection fraction (55.5%) and low‐to‐moderate surgical risk (Society of Thoracic Surgeons [STS] predicted risk of mortality [PROM] 4.1%). Technical and 30‐day device success rates were 95% and 90%, respectively; early safety rate at 30 days was 66%. At average 12 months follow‐up, all‐cause mortality was 10.2%. The most common complication was permanent pacemaker implantation (13%), followed by type 2 or greater bleeding (9.7%), acute kidney injury stage 3–4 (4.7%), major vascular events (4.3%), and stroke (3.0%). Moderate/severe paravalvular regurgitation and patient‐prosthesis mismatch occurred in 4% and 8%, respectively. Study‐level pooled predictor analyses showed that acute kidney injury, type 2 or greater bleeding, paravalvular regurgitation, non‐structural valve dysfunction, and higher STS score were associated with higher mortality, while eccentric/severe aortic valve calcification was associated with significant paravalvular regurgitation. Conclusions: Transcatheter aortic valve implantation shows high procedural success but non‐negligible complication rates under VARC‐3 criteria. acute kidney injury, type 2 or greater bleeding, NSVD, periprocedural stroke and myocardial infarction after transcatheter aortic valve implantation were associated with higher mortality.


  • Open Access

    Predictive Factors for Permanent Pacemaker Implantation and Mortality after Transcatheter Aortic Valve Replacement in Patients with Pre-Existing Atrial Fibrillation

    by Dan Osovsky, Elad Maor, Roy Beinart, Paul Fefer, Amit Segev, Ehud Regev, Tomer Ziv-Baran, Israel M. Barbash

    Introduction: Atrial fibrillation (AF) is the most common arrhythmia among patients undergoing transcatheter aortic valve replacement (TAVR). Post-TAVR permanent pacemaker implantation (PPI) predictors for patients in sinus rhythm were studied. However, scarce data are available about patients with AF. The aim of the study was to assess the prevalence of AF among patient undergoing TAVR, to identify predictors of PPI, and to study the association between PPI and long-term mortality. Methods: A historical cohort study of all patients who underwent TAVR between 2008 and 2022 in a large tertiary medical center was conducted. Patients with prior aortic valve bioprosthesis or pacemakers were excluded. Thirty-day PPI and 3-year mortality were studied. Univariate and multivariable analyses were performed. Results: Of the 1,579 patients who met the inclusion criteria, 405 (25.6%) had a history of AF either paroxysmal (17.1%) or persistent (8.4%). Among them, 49.9% were male and the mean age was 82 ± 6 years. The 30-day PPI rate was 21.7%. Right bundle branch block (RBBB, aOR 5.34, 95% CI: 2.79–10.21) and CoreValve/Evolut valve (aOR 2.51, 95% CI: 1.40–4.51) were significantly associated with 30-day PPI. PPI was not statistically significant associated with increased 3-year mortality. Conclusion: AF is prevalent among TAVR patients and PPI rates among this population are high. Predictors for PPI among patients with AF are similar to prior known predictors in patients with sinus rhythm and include baseline RBBB and transcatheter heart valve type. Despite the high PPI rates, there is no association between PPI and long-term mortality among patients with AF.

  • Open Access

    Long-Term Clinical Outcomes of Left Atrial Appendage Closure in Patients with Left Atrial Appendage Thrombus

    by Moshe Katz, Rotem Nahmias Oz, Eias Massalha, Avi Sabag, Eyal Nof, Israel Barbash, Paul Fefer, Victor Guetta, Roy Beinart

    Background: Patients with atrial fibrillation (AF) who have a high bleeding risk or contraindications to anticoagulation may be candidates for left atrial appendage closure (LAAC). However, the presence of a thrombus in the left atrial appendage (LAA) is generally considered a contraindication to the procedure. While the feasibility and short-term safety of LAAC in patients with pre-existing LAA thrombus has been reported, data on long-term outcomes remain limited. Objective: To assess the long-term clinical outcomes of AF patients undergoing LAAC in the presence of an LAA thrombus. Methods: This retrospective, single-center registry included all AF patients who underwent LAAC between June 2010 and April 2024. Patients were stratified based on the presence or absence of LAA thrombus at the time of the procedure. The primary endpoint was a 5-year composite of stroke, systemic embolism, or all-cause mortality. Results: A total of 403 patients underwent LAAC, of whom 24 (6%) had an LAA thrombus at the time of the procedure. During a median follow-up of 3.9 years, the primary endpoint occurred in 116 patients: 110 events (41%) in the no-thrombus group and 6 events (38%) in the thrombus group. There was no statistically significant difference in major adverse cardiovascular events (MACE) between groups (log-rank p = 0.862). Conclusions: LAAC may be performed safely in selected patients with distal LAA thrombus, with long-term outcomes comparable to those without thrombus.


  • Clinical significance and correlation of microRNA-21 expression in patients undergoing transcatheter aortic valve replacement

    by Anat Berkovitch, Zvi Sirotkin, Yoni Grossman, Victor Guetta, Paul Fefer, Amit Segev, Elad Maor, Gidi Paret, Shlomi Matetzky, Yael Nevo-Caspi, et al.

    A significant drop in circulating microRNA-21 levels 6 h after transcatheter aortic valve replacement (TAVR) was associated with a fourfold increased risk of major adverse cardiovascular or cerebrovascular events (MACCE). This prospective study identifies microRNA-21 as a promising early biomarker for risk stratification and prognosis after TAVR, offering potential for more personalized postprocedural care.

  • Open Access

    Effectiveness of the GPT-4o Model in Interpreting Electrocardiogram Images for Cardiac Diagnostics: Diagnostic Accuracy Study

    by Haya Engelstein, Roni Ramon-Gonen, Avi Sabbag, Eyal Klang, Karin Sudri, Michal Cohen-Shelly, Israel Barbash

    Background: Recent progress has demonstrated the potential of deep learning models in analyzing electrocardiogram (ECG) pathologies. However, this method is intricate, expensive to develop, and designed for specific purposes. Large language models show promise in medical image interpretation, and yet their effectiveness in ECG analysis remains understudied. Generative Pretrained Transformer 4 Omni (GPT-4o), a multimodal artificial intelligence model, capable of processing images and text without task-specific training, may offer an accessible alternative. Objective: This study aimed to evaluate GPT-4o’s effectiveness in interpreting 12-lead ECGs, assessing classification accuracy, and exploring methods to enhance its performance. Methods: A total of 6 common ECG diagnoses were evaluated: normal ECG, ST-segment elevation myocardial infarction, atrial fibrillation, right bundle branch block, left bundle branch block, and paced rhythm, with 30 normal ECGs and 10 of each abnormal pattern, totaling 80 cases. Deidentified ECGs were analyzed using OpenAI’s GPT-4o. Our study used both zero-shot and few-shot learning methodologies to investigate three main scenarios: (1) ECG image recognition, (2) binary classification of normal versus abnormal ECGs, and (3) multiclass classification into 6 categories. Results: The model excelled in recognizing ECG images, achieving an accuracy of 100%. In the classification of normal or abnormal ECG cases, the few-shot learning approach improved GPT-4o’s accuracy by 30% from the baseline, reaching 83% (95% CI 81.8%-84.6%). However, multiclass classification for a specific pathology remained limited, achieving only 41% accuracy. Conclusions: GPT-4o effectively differentiates normal from abnormal ECGs, suggesting its potential as an accessible artificial intelligence–assisted triage tool. Although limited in diagnosing specific cardiac conditions, GPT-4o’s capability to interpret ECG images without specialized training highlights its potential for preliminary ECG interpretation in clinical and remote settings.


  • Enhancing Coronary Revascularization Decisions: The Promising Role of Large Language Models as a Decision-Support Tool for Multidisciplinary Heart Team

    by Karin Sudri, Iris Motro-Feingold, Roni Ramon-Gonen, Noam Barda, Eyal Klang, Paul Fefer, Sergei Amunts, Zachi Itzhak Attia, Mohamad Alkhouli, Amitai Segev, et al.

    BACKGROUND: While clinical practice guidelines advocate for multidisciplinary heart team (MDHT) discussions in coronary revascularization, variability in implementation across health care settings remains a challenge. This variability could potentially be addressed by language learning models like ChatGPT, offering decision-making support in diverse health care environments. Our study aims to critically evaluate the concordance between recommendations made by MDHT and those generated by language learning models in coronary revascularization decision-making. METHODS: From March 2023 to July 2023, consecutive coronary angiography cases (n=86) that were referred for revascularization (either percutaneous or surgical) were analyzed using both ChatGPT-3.5 and ChatGPT-4. Case presentation formats included demographics, medical background, detailed description of angiographic findings, and SYNTAX score (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery; I and II), which were presented in 3 different formats. The recommendations of the models were compared with those of an MDHT. RESULTS: ChatGPT-4 showed high concordance with decisions made by the MDHT (accuracy 0.82, sensitivity 0.8, specificity 0.83, and kappa 0.59), while ChatGPT-3.5 (0.67, 0.27, 0.84, and 0.12, respectively) showed lower concordance. Entropy and Fleiss kappa of ChatGPT-4 were 0.09 and 0.9, respectively, indicating high reliability and repeatability. The best correlation between ChatGPT-4 and MDHT was achieved when clinical cases were presented in a detailed context. Specific subgroups of patients yielded high accuracy (>0.9) of ChatGPT-4, including those with left main disease, 3 vessel disease, and diabetic patients. CONCLUSIONS: The present study demonstrates that advanced language learning models like ChatGPT-4 may be able to predict clinical recommendations for coronary artery disease revascularization with reasonable accuracy, especially in specific patient groups, underscoring their potential role as a supportive tool in clinical decision-making.


  • Open Access

    Temporal Trends in Patient Characteristics and Clinical Outcomes of TAVR: Over a Decade of Practice

    by Nour Karra, Amir Sharon, Eias Massalha, Paul Fefer, Elad Maor, Victor Guetta, Sagit Ben-Zekry, Rafael Kuperstein, Shlomi Matetzky, Roy Beigel, et al.

    Background/Objective: Transcatheter aortic valve replacement (TAVR) is indicated for severe aortic stenosis patients with a prohibitive surgical risk. However, its use has been expanding in recent years to include intermediate- and low-risk patients. Thus, registry data describing changes in patient characteristics and outcomes are needed. The aim of this study was to analyse the temporal changes in patient profiles and clinical outcomes of all-comer TAVR. Methods: Baseline characteristics and VARC-3 outcomes of 1632 consecutive patients undergoing TAVR between 2008 and 2021 were analysed. Results: The annual rate of TAVR increased from 30 procedures in 2008–2009 to 398 in 2020–2021. Over the follow-up period, patient age decreased from 85 ± 4 to 80 ± 6.8 (p < 0.001) and the STS score decreased from 5.9% to 2.8% (p < 0.001). Procedural characteristics significantly changed, representing a shift into a minimally invasive approach: adoption of local anaesthesia (none to 48%, p < 0.001) and preference of transfemoral access (74% in 2011–2012 vs. 94.5% in 2020–2021, p < 0.001). The rates of almost all procedural complications decreased, including major vascular and bleeding complications, acute kidney injury (AKI) and in-hospital heart failure. There was a striking decline in rates of complete atrioventricular block (CAVB) and the need for a permanent pacemaker (PPM). PPM rates, however, remain high (17.8%). Thirty-day and one-year mortality significantly declined to 1.8% and 8.3%, respectively. Multivariable analysis shows that AKI, bleeding and stroke are strong predictors of one-year mortality (p < 0.001). Conclusions: The TAVR procedure has changed dramatically during the last 14 years in terms of patient characteristics, procedural aspects and device maturity. These shifts have led to improved procedural safety, contributing to improved short- and long-term patient outcomes.


  • Open Access

    Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival

    by Shmuel Tiosano, Ariel Banai, Wesam Mulla, Ido Goldenberg, Gabriella Bayshtok, Uri Amit, Nir Shlomo, Eyal Nof, Raphael Rosso, Michael Glikson, et al.

    Aim To compare the 1-year survival rate of patients with atrial fibrillation (AF) following left atrial appendage occluder (LAAO) implantation vs. treatment with novel oral anticoagulants (NOACs). Methods: We have conducted an indirect, retrospective comparison between LAAO and NOAC registries. The LAAO registry is a national prospective cohort of 419 AF patients who underwent percutaneous LAAO between January 2008 and October 2015. The NOACs registry is a multicenter prospective cohort of 3138 AF patients treated with NOACs between November 2015 and August 2018. Baseline patient characteristics were retrospectively collected from coded diagnoses of hospitalization and outpatient clinic notes. Follow-up data was sorted from coded diagnoses and the national civil registry. Subjects were matched according to propensity score. Baseline characteristics were compared using Chi-Square and student’s t-test. Survival analysis was performed using Kaplan-Meier survival curves, log-rank test, and multivariable Cox regression, adjusting for possible confounding variables. Results: This study included 114 subjects who underwent LAAO implantation and 342 subjects treated with NOACs. The mean age of participants was 77.9 ± 7.44 and 77.1 ± 11.2 years in the LAAO and NOAC groups, respectively (p = 0.4). The LAAO group had 70 (61%) men compared to 202 (59%) men in the NOAC group (p = 0.74). No significant differences were found in baseline comorbidities, renal function, or CHA2DS2-VASc score. One-year mortality was observed in 5 (4%) patients and 32 (9%) patients of the LAAO and NOAC groups, respectively. After adjusting for confounders, LAAO was significantly associated with a lower risk for 1-year mortality (HR 0.38, 95%CI 0.14–0.99). In patients with impaired renal function, this difference was even more prominent (HR 0.21 for creatinine clearance (CrCl) < 60 mL/min). Conclusions: In a pooled analysis of two registries, we found a significantly lower risk for 1-year mortality in patients with AF who were implanted with LAAO than those treated with NOACs. This finding was more prominent in patients with impaired renal function. Future prospective direct studies should further investigate the efficacy and adverse effects of both treatment strategies.


  • Management and outcome of patients with non-ST elevation myocardial infarction and intercurrent non-coronary precipitating events

    by Amir Sharon, Boris Fishman, Eias Massalha, Edward Itelman, Meir Mouallem, Paul Fefer, Israel M Barbash, Amit Segev, Shlomi Matetzky, Victor Guetta, et al.

    Aims: To evaluate the effect of an intercurrent non-coronary illness on the management and outcome of patients with non-ST-segment elevation myocardial infarction (NSTEMI). Methods and results: Consecutive hospitalized patients with a primary diagnosis of NSTEMI between August 2008 and December 2019 at Sheba Medical Center. All patients’ records were reviewed for the presence of a non-coronary precipitating event (NCPE): a major intercurrent acute non-coronary illness or condition, either cardiac or non-cardiac. The primary outcome was all-cause mortality. Cox regression with interaction analysis was applied. Final study population comprised 6491 patients, of whom 2621 (40%) had NCPEs. Patients with NCPEs were older (77 vs. 69 years) and more likely to have comorbidities. The most prevalent event was infection (35%, n = 922). During a median follow-up of 30 months, 2529 patients died. Patients with NCPEs were 43% more likely to die during follow-up in a multivariable model (95% CI: 1.31–1.55). Invasive strategy was associated with a 55% lower mortality among patients without NCPE and only 44% among patients with NCPE (P for interaction < 0.001). Dual antiplatelet therapy (DAPT) was associated with a 20% lower mortality in patients without NCEP and a non-significant mortality difference among patients with NCPE (P for interaction = 0.014). Sub-analysis by the specific NCPE showed the highest mortality risk among patients with infectious precipitant. The lower mortality associated with invasive strategy was not observed in this subgroup. Conclusion: Among NSTEMI patients, the presence of an NCPE is associated with poor survival and modifies the effect of management strategies.


  • Open Access

    Procedural and long‐term outcome among patients undergoing expedited trans‐catheter aortic valve replacement

    by Anat Berkovitch, Amit Segev, Victor Guetta, Ariel Finkelstein, Ran Kornowski, Haim Danenberg, Paul Fefer, Hana Vaknin Assa, Maayan Konigstein, Ilan Merdler, et al.

    Objective: Patients with rapidly deteriorating clinical status due to severe aortic stenosis are often referred for expedited transcatheter aortic valve replacement (TAVR). Data regarding the outcome of such interventions is limited. We aimed to evaluate the outcome of patients undergoing expedited TAVR.Design and Setting: Data were derived from the Israeli Multicenter Registry.Subjects: Subjects were divided into two groups based on procedure urgency: patients who were electively hospitalized for the procedure (N = 3140) and those who had an expedited TAVR (N = 142). Procedural and periprocedural complication rates were significantly higher among patients with an expedited indication for TAVR compared to those having an elective procedure: valve malposition 4.6% versus 0.6% (p < 0.001), procedural cardiopulmonary resuscitation 4.3% versus 1.0% (p = 0.007), postprocedure myocardial infarction 2.0% versus 0.4% (p = 0.002), and stage 3 acute kidney injury 3.0% versus 1.1%, (p < 0.001). Patients with expedited indication for TAVR had significantly higher in hospital mortality (5.6% vs. 1.4%, p = 0.003). Kaplan–Meier's survival analysis showed that patients undergoing expedited TAVR had higher 3‐year mortality rates compared to patients undergoing an elective TAVR procedure (p < 0.001). Multivariate analysis found that patients with expedited indication had fourfolds increased risk of in‐hospital mortality (odds ratio: 4.07, p = 0.001), and nearly twofolds increased risk of mortality at 3‐year (hazard ratio: 1.69, p = 0.001) compared to those having an elective procedure.Conclusion: Patients with expedited indications for TAVR suffer from poor short‐ and long‐term outcomes. It is important to characterize and identify these patients before the deterioration to perform TAVR in a fast‐track pathway to minimize their procedural risk.